507 related articles for article (PubMed ID: 37443100)
1. Role of N6-methyladenosine RNA modification in gastric cancer.
Ding SQ; Zhang XP; Pei JP; Bai X; Ma JJ; Zhang CD; Dai DQ
Cell Death Discov; 2023 Jul; 9(1):241. PubMed ID: 37443100
[TBL] [Abstract][Full Text] [Related]
2. Potential role of N6-methyladenosine modification in the development of Parkinson's disease.
Zhou J; Han Y; Hou R
Front Cell Dev Biol; 2023; 11():1321995. PubMed ID: 38155838
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
[TBL] [Abstract][Full Text] [Related]
4. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
[TBL] [Abstract][Full Text] [Related]
5. Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia.
Fang Z; Ding H; Han J; Fu L; Jin J; Feng W
J Leukoc Biol; 2024 May; ():. PubMed ID: 38721720
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in Cancer.
Tian S; Lai J; Yu T; Li Q; Chen Q
Front Oncol; 2020; 10():623634. PubMed ID: 33552994
[TBL] [Abstract][Full Text] [Related]
7. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
8. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
Fang X; Li M; Yu T; Liu G; Wang J
Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
[TBL] [Abstract][Full Text] [Related]
9. The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma.
He C; Teng X; Wang L; Ni M; Zhu L; Liu J; Lv W; Hu J
Mol Biol Rep; 2023 Oct; 50(10):8691-8703. PubMed ID: 37598390
[TBL] [Abstract][Full Text] [Related]
10. Function of N6-Methyladenosine Modification in Tumors.
Zhang N; Zuo Y; Peng Y; Zuo L
J Oncol; 2021; 2021():6461552. PubMed ID: 34858499
[TBL] [Abstract][Full Text] [Related]
11. Association of N6-methyladenosine with viruses and related diseases.
Wu F; Cheng W; Zhao F; Tang M; Diao Y; Xu R
Virol J; 2019 Nov; 16(1):133. PubMed ID: 31711514
[TBL] [Abstract][Full Text] [Related]
12. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
[TBL] [Abstract][Full Text] [Related]
13. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.
Imam H; Kim GW; Siddiqui A
Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128
[TBL] [Abstract][Full Text] [Related]
14. RNA N6-methyladenosine methylation and skin diseases.
Yu Y; Lu S; Jin H; Zhu H; Wei X; Zhou T; Zhao M
Autoimmunity; 2023 Dec; 56(1):2167983. PubMed ID: 36708146
[TBL] [Abstract][Full Text] [Related]
15. Functions of N6-methyladenosine and its role in cancer.
He L; Li H; Wu A; Peng Y; Shu G; Yin G
Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
[TBL] [Abstract][Full Text] [Related]
16. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.
Liu Q
Front Genet; 2021; 12():825109. PubMed ID: 35087575
[TBL] [Abstract][Full Text] [Related]
17. Association of N6-methyladenosine with viruses and virally induced diseases.
Wu F; Cheng W; Zhao F; Tang M; Diao Y; Xu R
Front Biosci (Landmark Ed); 2020 Mar; 25(6):1184-1201. PubMed ID: 32114429
[TBL] [Abstract][Full Text] [Related]
18. Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
Liu WW; Wang H; Zhu XY
Biomark Res; 2022 Aug; 10(1):64. PubMed ID: 35999621
[TBL] [Abstract][Full Text] [Related]
19. RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis.
Ma W; Wu T
Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1190-C1205. PubMed ID: 36036444
[TBL] [Abstract][Full Text] [Related]
20. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
Front Oncol; 2021; 11():635329. PubMed ID: 33928028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
